| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,429 |
9,285 |
$275K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,599 |
7,551 |
$228K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,098 |
8,610 |
$141K |
| 94060 |
|
3,274 |
2,601 |
$56K |
| 94729 |
|
3,272 |
2,603 |
$54K |
| 95816 |
|
1,163 |
333 |
$50K |
| 94727 |
|
3,268 |
2,603 |
$43K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
556 |
441 |
$35K |
| 93000 |
|
4,498 |
3,690 |
$31K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,713 |
2,489 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
3,916 |
3,106 |
$21K |
| 99307 |
|
2,521 |
2,319 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,983 |
2,048 |
$18K |
| 96112 |
|
716 |
194 |
$16K |
| 20610 |
|
481 |
317 |
$8K |
| 82947 |
|
6,501 |
4,750 |
$8K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
478 |
395 |
$7K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
6,351 |
3,449 |
$6K |
| 93224 |
|
138 |
132 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,121 |
5,962 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
240 |
175 |
$4K |
| 95957 |
|
117 |
56 |
$4K |
| 90686 |
|
473 |
376 |
$3K |
| 90756 |
|
361 |
277 |
$3K |
| 80305 |
|
356 |
283 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
280 |
226 |
$2K |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
1,143 |
501 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,306 |
4,928 |
$1K |
| 81003 |
|
1,455 |
1,011 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,441 |
2,472 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
214 |
136 |
$975.92 |
| 90656 |
|
141 |
101 |
$965.45 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,412 |
1,248 |
$799.50 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
78 |
66 |
$608.89 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
23 |
$488.91 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,228 |
738 |
$415.62 |
| 96132 |
|
34 |
26 |
$394.24 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
20 |
12 |
$372.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
44 |
$334.84 |
| 99304 |
|
17 |
14 |
$306.51 |
| 72100 |
|
42 |
27 |
$196.09 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
748 |
490 |
$150.75 |
| 74018 |
|
23 |
19 |
$129.90 |
| G0008 |
Administration of influenza virus vaccine |
485 |
374 |
$107.93 |
| 95012 |
|
40 |
28 |
$100.91 |
| 99499 |
|
388 |
236 |
$0.00 |
| 99080 |
|
388 |
313 |
$0.00 |
| 90901 |
|
63 |
25 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
52 |
30 |
$0.00 |